ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
今天上午美国股票期货涨跌互现，纳斯达克期货周二上涨约50点。
Shares of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) fell sharply in today's pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint.
阿卡迪亚制药公司（纳斯达克股票代码：ACAD）的股价在今天的盘前交易中大幅下跌，此前该公司报告称，评估皮马万色林治疗精神分裂症阴性症状的第三阶段 ADVANCE-2 试验未达到主要终点。
ACADIA Pharmaceuticals shares dipped 17.4% to $19.93 in pre-market trading.
阿卡迪亚制药公司股价在盘前交易中下跌17.4％，至19.93美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是一些在今天的盘前交易时段中录得亏损的大型股票。
- Power & Digital Infrastructure Acquisition II Corp. (NASDAQ:XPDB) shares tumbled 12.6% to $25.57 in pre-market trading after surging 181% on Monday.
- Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares fell 5.9% to $9.16 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
- Aeva Technologies, Inc. (NASDAQ:AEVA) shares declined 5.4% to $1.23 in pre-market trading. Aeva said it expects a 1-for-5 reverse stock split of its outstanding shares of common stock will be effective as of March 18, 2024.
- PLDT Inc. (NYSE:PHI) fell 3.8% to $25.95 in pre-market trading after jumping over 16% on Monday.
- NextNav Inc. (NASDAQ:NN) declined 3.6% to $5.07 in pre-market trading. NextNav shares jumped 35% on Monday after the company announced it signed an agreement to acquire spectrum licenses covering an additional 4 MHz in the lower 900 MHz band.
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares fell 3.2% to $2.72 in pre-market trading. Lexicon shares surged over 29% on Monday after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
- Asana, Inc. (NYSE:ASAN) shares fell 2.4% to $18.35 in pre-market trading following fourth-quarter results.
- 电力和数字基础设施收购二公司（纳斯达克股票代码：XPDB）股价在周一飙升181％后，在盘前交易中下跌12.6％，至25.57美元。
- Ocular Therapeutix, Inc.（纳斯达克股票代码：OCUL）股价在盘前交易中下跌5.9％，至9.16美元，此前该公司公布的第四季度财务业绩低于预期。
- Aeva Technologies, Inc.（纳斯达克股票代码：AEVA）股价在盘前交易中下跌5.4％，至1.23美元。Aeva表示，预计其已发行普通股的1比5反向股票拆分将从2024年3月18日起生效。
- PLDT Inc.（纽约证券交易所代码：PHI）在周一上涨超过16％后，在盘前交易中下跌3.8％，至25.95美元。
- NextNav Inc.（纳斯达克股票代码：NN）在盘前交易中下跌3.6％，至5.07美元。周一，NextNav股价上涨了35％，此前该公司宣布签署了一项协议，以收购涵盖900 MHz较低频段中另外4兆赫频段的频谱许可。
- Lexicon Pharmicals, Inc.（纳斯达克股票代码：LXRX）股价在盘前交易中下跌3.2％，至2.72美元。周一，Lexicon股价飙升了29％以上，此前该公司表示准备根据美国食品药品管理局的反馈重新提交其针对1型糖尿病的Sotagliflozin保密协议。此外，该公司宣布了一项证券购买协议，预计总收益约为2.5亿美元。
- 继第四季度业绩公布后，Asana公司（纽约证券交易所代码：ASAN）股价在盘前交易中下跌2.4％，至18.35美元。
Now Read This: Top 5 Risk Off Stocks That May Plunge This Quarter
现在读这个： 本季度可能暴跌的五大避险股票
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道